vs
Martin Marietta Materials（MLM）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Martin Marietta Materials的1.2倍（$1.4B vs $1.1B），瑞思迈净利率更高（27.6% vs 24.5%，领先3.1%），瑞思迈同比增速更快（11.0% vs -30.1%），Martin Marietta Materials自由现金流更多（$424.0M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs -4.5%）
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
MLM vs RMD — 直观对比
营收规模更大
RMD
是对方的1.2倍
$1.1B
营收增速更快
RMD
高出41.1%
-30.1%
净利率更高
RMD
高出3.1%
24.5%
自由现金流更多
MLM
多$112.8M
$311.2M
两年增速更快
RMD
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $279.0M | $392.6M |
| 毛利率 | 35.0% | 61.8% |
| 营业利润率 | 24.6% | 34.6% |
| 净利率 | 24.5% | 27.6% |
| 营收同比 | -30.1% | 11.0% |
| 净利润同比 | -4.8% | 13.9% |
| 每股收益（稀释后） | $4.59 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLMRMD
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.8B | $1.3B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.8B | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
净利润MLMRMD
| Q4 25 | $279.0M | $392.6M | ||
| Q3 25 | $414.0M | $348.5M | ||
| Q2 25 | $328.0M | $379.7M | ||
| Q1 25 | $116.0M | $365.0M | ||
| Q4 24 | $293.0M | $344.6M | ||
| Q3 24 | $363.0M | $311.4M | ||
| Q2 24 | $294.0M | $292.2M | ||
| Q1 24 | $1.0B | $300.5M |
毛利率MLMRMD
| Q4 25 | 35.0% | 61.8% | ||
| Q3 25 | 33.1% | 61.5% | ||
| Q2 25 | 30.0% | 60.8% | ||
| Q1 25 | 24.8% | 59.3% | ||
| Q4 24 | 30.0% | 58.6% | ||
| Q3 24 | 31.7% | 58.6% | ||
| Q2 24 | 29.3% | 58.5% | ||
| Q1 24 | 21.7% | 57.9% |
营业利润率MLMRMD
| Q4 25 | 24.6% | 34.6% | ||
| Q3 25 | 27.4% | 33.4% | ||
| Q2 25 | 25.3% | 33.7% | ||
| Q1 25 | 14.3% | 33.0% | ||
| Q4 24 | 24.4% | 32.5% | ||
| Q3 24 | 25.9% | 31.6% | ||
| Q2 24 | 22.6% | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率MLMRMD
| Q4 25 | 24.5% | 27.6% | ||
| Q3 25 | 22.4% | 26.1% | ||
| Q2 25 | 18.1% | 28.2% | ||
| Q1 25 | 8.6% | 28.3% | ||
| Q4 24 | 18.0% | 26.9% | ||
| Q3 24 | 19.2% | 25.4% | ||
| Q2 24 | 16.7% | 23.9% | ||
| Q1 24 | 83.5% | 25.1% |
每股收益（稀释后）MLMRMD
| Q4 25 | $4.59 | $2.68 | ||
| Q3 25 | $6.85 | $2.37 | ||
| Q2 25 | $5.43 | $2.58 | ||
| Q1 25 | $1.90 | $2.48 | ||
| Q4 24 | $4.87 | $2.34 | ||
| Q3 24 | $5.91 | $2.11 | ||
| Q2 24 | $4.76 | $1.97 | ||
| Q1 24 | $16.87 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.0M | $1.4B |
| 总债务越低越好 | $5.3B | $403.9M |
| 股东权益账面价值 | $10.0B | $6.3B |
| 总资产 | $18.7B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.53× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MLMRMD
| Q4 25 | $67.0M | $1.4B | ||
| Q3 25 | $57.0M | $1.4B | ||
| Q2 25 | $225.0M | $1.2B | ||
| Q1 25 | $101.0M | $932.7M | ||
| Q4 24 | $670.0M | $521.9M | ||
| Q3 24 | $52.0M | $426.4M | ||
| Q2 24 | $109.0M | $238.4M | ||
| Q1 24 | $2.6B | $237.9M |
总债务MLMRMD
| Q4 25 | $5.3B | $403.9M | ||
| Q3 25 | $5.5B | $408.7M | ||
| Q2 25 | $5.4B | $658.4M | ||
| Q1 25 | $5.4B | $663.1M | ||
| Q4 24 | $5.4B | $662.9M | ||
| Q3 24 | $4.0B | $667.6M | ||
| Q2 24 | $4.3B | $697.3M | ||
| Q1 24 | $4.3B | $997.0M |
股东权益MLMRMD
| Q4 25 | $10.0B | $6.3B | ||
| Q3 25 | $9.7B | $6.1B | ||
| Q2 25 | $9.4B | $6.0B | ||
| Q1 25 | $9.1B | $5.5B | ||
| Q4 24 | $9.5B | $5.3B | ||
| Q3 24 | $9.2B | $5.2B | ||
| Q2 24 | $8.8B | $4.9B | ||
| Q1 24 | $8.9B | $4.6B |
总资产MLMRMD
| Q4 25 | $18.7B | $8.5B | ||
| Q3 25 | $18.7B | $8.3B | ||
| Q2 25 | $18.1B | $8.2B | ||
| Q1 25 | $17.7B | $7.6B | ||
| Q4 24 | $18.2B | $7.1B | ||
| Q3 24 | $16.5B | $7.2B | ||
| Q2 24 | $16.3B | $6.9B | ||
| Q1 24 | $16.2B | $6.8B |
负债/权益比MLMRMD
| Q4 25 | 0.53× | 0.06× | ||
| Q3 25 | 0.57× | 0.07× | ||
| Q2 25 | 0.58× | 0.11× | ||
| Q1 25 | 0.60× | 0.12× | ||
| Q4 24 | 0.57× | 0.13× | ||
| Q3 24 | 0.44× | 0.13× | ||
| Q2 24 | 0.49× | 0.14× | ||
| Q1 24 | 0.49× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $629.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $424.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 37.2% | 21.9% |
| 资本支出强度资本支出/营收 | 18.0% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.25× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $978.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流MLMRMD
| Q4 25 | $629.0M | $339.7M | ||
| Q3 25 | $551.0M | $457.3M | ||
| Q2 25 | $387.0M | $538.8M | ||
| Q1 25 | $218.0M | $578.7M | ||
| Q4 24 | $686.0M | $308.6M | ||
| Q3 24 | $600.0M | $325.5M | ||
| Q2 24 | $1.0M | $440.1M | ||
| Q1 24 | $172.0M | $402.0M |
自由现金流MLMRMD
| Q4 25 | $424.0M | $311.2M | ||
| Q3 25 | $361.0M | $414.4M | ||
| Q2 25 | $208.0M | $508.2M | ||
| Q1 25 | $-15.0M | $557.9M | ||
| Q4 24 | $453.0M | $288.0M | ||
| Q3 24 | $317.0M | $307.7M | ||
| Q2 24 | $-138.0M | $415.2M | ||
| Q1 24 | $-28.0M | $380.8M |
自由现金流率MLMRMD
| Q4 25 | 37.2% | 21.9% | ||
| Q3 25 | 19.6% | 31.0% | ||
| Q2 25 | 11.5% | 37.7% | ||
| Q1 25 | -1.1% | 43.2% | ||
| Q4 24 | 27.8% | 22.5% | ||
| Q3 24 | 16.8% | 25.1% | ||
| Q2 24 | -7.8% | 33.9% | ||
| Q1 24 | -2.2% | 31.8% |
资本支出强度MLMRMD
| Q4 25 | 18.0% | 2.0% | ||
| Q3 25 | 10.3% | 3.2% | ||
| Q2 25 | 9.9% | 2.3% | ||
| Q1 25 | 17.2% | 1.6% | ||
| Q4 24 | 14.3% | 1.6% | ||
| Q3 24 | 15.0% | 1.5% | ||
| Q2 24 | 7.9% | 2.0% | ||
| Q1 24 | 16.0% | 1.8% |
现金转化率MLMRMD
| Q4 25 | 2.25× | 0.87× | ||
| Q3 25 | 1.33× | 1.31× | ||
| Q2 25 | 1.18× | 1.42× | ||
| Q1 25 | 1.88× | 1.59× | ||
| Q4 24 | 2.34× | 0.90× | ||
| Q3 24 | 1.65× | 1.05× | ||
| Q2 24 | 0.00× | 1.51× | ||
| Q1 24 | 0.16× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLM
| Building Materials Business East Group | $774.0M | 68% |
| Building Materials Business West Group | $233.0M | 20% |
| Services | $88.0M | 8% |
| Other | $45.0M | 4% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
